Cardiac-specific overexpression of AT1 receptor mutant lacking G alpha q/G alpha i coupling causes hypertrophy and bradycardia in transgenic mice.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Journal of Clinical Investigation

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 16276415PMCID PMC1265872
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Oligomerization of Wild Type and Nonfunctional Mutant Angiotensin II Type I Receptors Inhibits Gαq Protein Signaling but Not ERK Activation*

  2004cited by this paper
• Mechanical stress activates angiotensin II type 1 receptor without the involvement of angiotensin II

  2004cited by this paper
• Silent Information Regulator 2&agr;, a Longevity Factor and Class III Histone Deacetylase, Is an Essential Endogenous Apoptosis Inhibitor in Cardiac Myocytes

  2004cited by this paper
• Nkx2-5 pathways and congenital heart disease; loss of ventricular myocyte lineage specification leads to progressive cardiomyopathy and complete heart block.

  2004cited by this paper
• Phosphorylation of Eukaryotic Translation Initiation Factor 2Bε by Glycogen Synthase Kinase-3β Regulates β-Adrenergic Cardiac Myocyte Hypertrophy

  2004cited by this paper
• Reciprocal Regulation of Angiotensin Receptor-activated Extracellular Signal-regulated Kinases by β-Arrestins 1 and 2*

  2004cited by this paper
• Ca(2+)-sensitive tyrosine kinase Pyk2/CAK beta-dependent signaling is essential for G-protein-coupled receptor agonist-induced hypertrophy.

  2004cited by this paper
• Intracellular and Extracellular Angiotensin II Enhance the L-Type Calcium Current in the Failing Heart

  2004cited by this paper
• Gene dose-dependent atrial arrhythmias, heart block, and brady-cardiomyopathy in mice overexpressing A(3) adenosine receptors.

  2004cited by this paper
• Activation of Mst1 causes dilated cardiomyopathy by stimulating apoptosis without compensatory ventricular myocyte hypertrophy.

  2003cited by this paper
• Structural determinants for the activation mechanism of the angiotensin II type 1 receptor differ for phosphoinositide hydrolysis and mitogen-activated protein kinase pathways.

  2003cited by this paper
• Phosphorylation of Tyrosine 319 of the Angiotensin II Type 1 Receptor Mediates Angiotensin II-induced Trans-activation of the Epidermal Growth Factor Receptor*

  2003cited by this paper
• Focal Adhesion Kinase Is Activated and Mediates the Early Hypertrophic Response to Stretch in Cardiac Myocytes

  2003cited by this paper
• RSK2 Activity Is Regulated by Its Interaction with PEA-15*

  2003cited by this paper
• Mitochondrial death protein Nix is induced in cardiac hypertrophy and triggers apoptotic cardiomyopathy

  2002cited by this paper
• Side-chain substitutions within angiotensin II reveal different requirements for signaling, internalization, and phosphorylation of type 1A angiotensin receptors.

  2002cited by this paper
• Functional Roles of Ca(v)1.3 (alpha(1D)) calcium channel in sinoatrial nodes: insight gained using gene-targeted null mutant mice.

  2002cited by this paper
• AT1 Receptor Mutant Lacking Heterotrimeric G Protein Coupling Activates the Src-Ras-ERK Pathway without Nuclear Translocation of ERKs*

  2002cited by this paper
• The angiotensin II type I receptor-associated protein, ATRAP, is a transmembrane protein and a modulator of angiotensin II signaling.

  2002cited by this paper
• G-Protein-coupled receptor oligomerization and its potential for drug discovery

  2002cited by this paper
• β-Arrestin Scaffolding of the ERK Cascade Enhances Cytosolic ERK Activity but Inhibits ERK-mediated Transcription following Angiotensin AT1a Receptor Stimulation*

  2002cited by this paper
• Tyrosine Kinase Activation by the Angiotensin II Receptor in the Absence of Calcium Signaling*

  2001cited by this paper
• G-proteins in growth and apoptosis: lessons from the heart

  2001cited by this paper
• Protein-protein interactions at G-protein-coupled receptors.

  2001cited by this paper
• PEA-15 mediates cytoplasmic sequestration of ERK MAP kinase.

  2001cited by this paper
• Angiotensin II stimulates cardiac L-type Ca(2+) current by a Ca(2+)- and protein kinase C-dependent mechanism.

  2001cited by this paper
• The angiotensin II type 1 receptor and receptor-associated proteins

  2001cited by this paper
• G-protein-coupled receptors and signaling networks: emerging paradigms.

  2001cited by this paper
• Cytoplasmic signaling pathways that regulate cardiac hypertrophy.

  2001cited by this paper
• ANG II type 1 receptor downregulation does not require receptor endocytosis or G protein coupling.

  2001cited by this paper
• Complete heart block and sudden death in mice overexpressing calreticulin.

  2001cited by this paper
• The Renin-Angiotensin System in the Twenty-first Century

  2001cited by this paper
• Overexpression of angiotensin II type I receptor in cardiomyocytes induces cardiac hypertrophy and remodeling.

  2000cited by this paper
• Congenital deafness and sinoatrial node dysfunction in mice lacking class D L-type Ca2+ channels.

  2000cited by this paper
• The MEK1–ERK1/2 signaling pathway promotes compensated cardiac hypertrophy in transgenic mice

  2000cited by this paper
• AT1-receptor heterodimers show enhanced G-protein activation and altered receptor sequestration

  2000cited by this paper
• The conserved phosphoinositide 3‐kinase pathway determines heart size in mice

  2000cited by this paper
• Replacement by homologous recombination of the minK gene with lacZ reveals restriction of minK expression to the mouse cardiac conduction system.

  1999cited by this paper
• Heptahelical Receptor Signaling: Beyond the G Protein Paradigm

  1999cited by this paper
• Cardiac-specific overexpression of RhoA results in sinus and atrioventricular nodal dysfunction and contractile failure.

  1999cited by this paper
• PKC-dependent activation of p44/p42 MAPKs during myocardial ischemia-reperfusion in conscious rabbits.

  1999cited by this paper
• Conditional expression and signaling of a specifically designed Gi-coupled receptor in transgenic mice

  1999cited by this paper
• Molecular tinkering of G protein‐coupled receptors: an evolutionary success

  1999cited by this paper
• Cardiac-specific overexpression of Galphaq alters excitation-contraction coupling in isolated cardiac myocytes.

  1999cited by this paper
• Versatility of the angiotensin II type 1 receptor.

  1998cited by this paper
• Regulation of angiotensin II-induced JAK2 tyrosine phosphorylation: roles of SHP-1 and SHP-2.

  1998cited by this paper
• Endothelin Induces a Calcium‐Dependent Phosphorylation of PEA‐15 in Intact Astrocytes: Identification of Ser104 and Ser116 Phosphorylated, Respectively, by Protein Kinase C and Calcium/Calmodulin Kinase II In Vitro

  1998cited by this paper
• Angiotensin II-induced Association of Phospholipase Cγ1 with the G-protein-coupled AT1 Receptor*

  1998cited by this paper
• Oncogenic src, raf, and rasStimulate a Hypertrophic Pattern of Gene Expression and Increase Cell Size in Neonatal Rat Ventricular Myocytes*

  1998cited by this paper
• Decompensation of pressure-overload hypertrophy in G alpha q-overexpressing mice.

  1998cited by this paper
• Dependence on the Motif YIPP for the Physical Association of Jak2 Kinase with the Intracellular Carboxyl Tail of the Angiotensin II AT1 Receptor*

  1997cited by this paper
• Overexpression of angiotensin AT1 receptor transgene in the mouse myocardium produces a lethal phenotype associated with myocyte hyperplasia and heart block.

  1997cited by this paper
• Phospholamban deficiency alters inactivation kinetics of L-type Ca2+ channels in mouse ventricular myocytes.

  1997cited by this paper
• The cellular and molecular response of cardiac myocytes to mechanical stress.

  1997cited by this paper
• Angiotensin-converting enzyme inhibition and ventricular remodeling after myocardial infarction.

  1995cited by this paper
• Regulation of blood pressure by the type 1A angiotensin II receptor gene.

  1995cited by this paper
• Direct stimulation of Jak/STAT pathway by the angiotensin II AT1 receptor

  1995cited by this paper
• Mapping of G protein coupling sites of the angiotensin II type 1 receptor.

  1995cited by this paper
• Characterization of Rhodopsin Mutants That Bind Transducin but Fail to Induce GTP Nucleotide Uptake

  1995cited by this paper
• Angiotensin II receptor pharmacology.

  1994cited by this paper
• Is an Intracellular Renin–Angiotensin System Involved in Control of Cell Communication in Heart?

  1994cited by this paper
• Autocrine release of angiotensin II mediates stretch-induced hypertrophy of cardiac myocytes in vitro.

  1993cited by this paper
• Cardiac pacemaking in the sinoatrial node.

  1993cited by this paper
• Domains for G-protein coupling in angiotensin II receptor type I: studies by site-directed mutagenesis.

  1992cited by this paper
• Intracardiac detection of angiotensinogen and renin: a localized renin-angiotensin system in neonatal rat heart.

  1992cited by this paper
• Characterization of angiotensin II receptor subtypes in rat heart.

  1992cited by this paper
• Cardiac actions of angiotensin II: Role of an intracardiac renin-angiotensin system.

  1992cited by this paper
• In vitro autoradiographic localization of binding to angiotensin receptors in the rat heart.

  1990cited by this paper

• Cardiac Hypertrophy at the Crossroads: Mechanistic Insights and Emerging Multimodal Therapeutic Strategies.

  2025cites this paper
• IFN-γ-STAT1-ERK Pathway Mediates Protective Effects of Invariant Natural Killer T Cells Against Doxorubicin-Induced Cardiomyocyte Death

  2023cites this paper
• Interactions between AT1R and GRKs: the determinants for activation of signaling pathways involved in blood pressure regulation

  2023cites this paper
• Adaptive and maladaptive roles of different angiotensin receptors in the development of cardiac hypertrophy and heart failure.

  2023cites this paper
• Gαq protein-biased ligand of angiotensin II type 1 receptor mediates myofibroblast differentiation through TGF-β1/ERK axis in human cardiac fibroblasts.

  2023cites this paper
• Neurohormonal Connections with Mitochondria in Cardiomyopathy and Other Diseases.

  2022cites this paper
• Targeting GPCRs and Their Signaling as a Therapeutic Option in Melanoma

  2022cites this paper
• Pathophysiology and pharmacology of G protein-coupled receptors in the heart.

  2022cites this paper
• Sustained AT1R stimulation induces upregulation of growth factors in human cardiac fibroblasts via Gαq/TGF-β/ERK signaling that influences myocyte hypertrophy.

  2022cites this paper
• Angiotensin II-Induced Signal Transduction Mechanisms for Cardiac Hypertrophy

  2022cites this paper
• Double life: How GRK2 and β-arrestin signaling participate in diseases

  2022cites this paper
• Beta-Arrestins in the Treatment of Heart Failure Related to Hypertension: A Comprehensive Review

  2021cites this paper
• Cardiovascular angiotensin II type 1 receptor biased signalling: Focus on non-Gq-, non-βarrestin-dependent signalling.

  2021cites this paper
• GFAT2 mediates cardiac hypertrophy through HBP-O-GlcNAcylation-Akt pathway.

  2021cites this paper
• Beta‐arrestin 2 mediates cardiac hypertrophy induced by thyroid hormones via AT1R

  2020cites this paper
• C-C chemokine receptor 5 signaling contributes to cardiac remodeling and dysfunction under pressure overload

  2020cites this paper
• DPP (Dipeptidyl Peptidase)-4 Inhibitor Attenuates Ang II (Angiotensin II)–Induced Cardiac Hypertrophy via GLP (Glucagon-Like Peptide)-1–Dependent Suppression of Nox (Nicotinamide Adenine Dinucleotide Phosphate Oxidase) 4-HDAC (Histone Deacetylase) 4 Pathway

  2020cites this paper
• The Role of β-Arrestin Proteins in Organization of Signaling and Regulation of the AT1 Angiotensin Receptor

  2019cites this paper
• Angiotensin II induces apoptosis of human right and left ventricular endocardial endothelial cells by activating the AT2 receptor 1.

  2019cites this paper
• Inflammation in non-ischemic heart disease: initiation by cardiomyocyte CaMKII and NLRP3 inflammasome signaling.

  2019cites this paper
• Not all arrestins are created equal: Therapeutic implications of the functional diversity of the β-arrestins in the heart

  2019cites this paper
• Hot topics in opioid pharmacology: mixed and biased opioids.

  2019cites this paper
• ERK: A Key Player in the Pathophysiology of Cardiac Hypertrophy

  2019cites this paper
• Arrestins in the Cardiovascular System: An Update.

  2018cites this paper
• Novel mechanisms of G-protein-coupled receptors functions: AT1 angiotensin receptor acts as a signaling hub and focal point of receptor cross-talk.

  2018cites this paper
• Increased Gi protein signaling potentiates the negative chronotropic effect of adenosine in the SHR right atrium

  2018cites this paper
• G-Protein–Coupled Receptors in Heart Disease

  2018cites this paper
• Cardiovascular Adaptations Induced by Resistance Training in Animal Models

  2018cites this paper
• GRK2 Mediates Arginine Vasopressin-Induced Interleukin-6 Production via Nuclear Factor-κB Signaling Neonatal Rat Cardiac Fibroblast

  2017cites this paper
• The Diverse Roles of Arrestin Scaffolds in G Protein–Coupled Receptor Signaling

  2017cites this paper
• Agents with vasodilator properties in acute heart failure.

  2017cites this paper
• GRK2/β‐arrestin mediates arginine vasopressin‐induced cardiac fibroblast proliferation

  2017cites this paper
• GRK2 mediates arginine vasopressin-induced IL-6 production via NF-k B signaling in neonatal rat cardiac fibroblasts

  2016influential citation
• Reduction in Na(+) current by angiotensin II is mediated by PKCα in mouse and human-induced pluripotent stem cell-derived cardiomyocytes.

  2016cites this paper
• Vasopressin V1A receptor mediates cell proliferation through GRK2-EGFR-ERK1/2 pathway in A7r5 cells.

  2016cites this paper
• Angiotensin II induces interleukin-6 expression in astrocytes: Role of reactive oxygen species and NF-κB.

  2016cites this paper
• GRK 2 / β-arrestin mediates arginine vasopressin-induced cardiac fibroblast proliferation Running title : GRK 2 / β-arrestinmediates cell proliferation

  2016cites this paper
• Biased Agonism of G Protein-Coupled Receptors: A Potential Therapeutic Strategy of Cardiovascular Diseases

  2016influential citation
• Biophysical insights into the molecular pharmacology of angiotensin II receptor heteromers

  2016cites this paper
• GPCR signaling and cardiac function.

  2015cites this paper
• International Union of Basic and Clinical Pharmacology. XCIX. Angiotensin Receptors: Interpreters of Pathophysiological Angiotensinergic Stimuli

  2015cites this paper
• Minireview: Role of intracellular scaffolding proteins in the regulation of endocrine G protein-coupled receptor signaling.

  2015cites this paper
• The emerging roles of β-arrestins in fibrotic diseases

  2015cites this paper
• Biased signalling: the instinctive skill of the cell in the selection of appropriate signalling pathways.

  2015cites this paper
• Regulation of CaMKII signaling in cardiovascular disease

  2015cites this paper
• Losartan counteracts the hyper-reactivity to angiotensin II and ROCK 1 over-activation in aortas isolated from streptozotocin-injected diabetic rats

  2015cites this paper
• Characterization of ß-arrestins trafficking and signaling functions on G protein-coupled receptors

  2015cites this paper
• Biased Agonism of the Angiotensin II Type I Receptor.

  2015cites this paper
• Multiple functions of G protein-coupled receptor kinases

  2014cites this paper
• Src Is Required for Mechanical Stretch-Induced Cardiomyocyte Hypertrophy through Angiotensin II Type 1 Receptor-Dependent β-Arrestin2 Pathways

  2014cites this paper
• Insights into the activation and inhibition of angiotensin II type 1 receptor in the mechanically loaded heart.

  2014cites this paper
• Overexpression of PEP-19 suppresses angiotensin II-induced cardiomyocyte hypertrophy.

  2014cites this paper
• Atrial endothelial impairment through Toll-like receptor 4 signaling causes atrial thrombogenesis

  2014cites this paper
• Molecular Determinants of Orexin Receptor Ligand Interaction : Studies on Ligand Selectivity and Impact of Calcium

  2014cites this paper
• Quantifying biased β-arrestin signaling.

  2014cites this paper
• Valsartan Regulates Myocardial Autophagy and Mitochondrial Turnover in Experimental Hypertension

  2014cites this paper
• Muscle-Specific RING Finger 1 Negatively Regulates Pathological Cardiac Hypertrophy Through Downregulation of Calcineurin A

  2014cites this paper
• Apelin receptor: its responsiveness to stretch mechanisms and its potential for cardiovascular therapy

  2014cites this paper
• The Role of Type 1 Angiotensin Receptors on T Lymphocytes in Cardiovascular and Renal Diseases

  2013cites this paper
• Activation of MAPK by inverse agonists in six naturally occurring constitutively active mutant human melanocortin-4 receptors.

  2013cites this paper
• Current and future G protein-coupled receptor signaling targets for heart failure therapy

  2013influential citation
• Solving the Cardiac Hypertrophy Riddle: The Angiotensin II–Mechanical Stress Connection

  2013cites this paper
• Arrestin pathways as drug targets.

  2013cites this paper
• Changes in Systolic and Diastolic Function in a Mouse Model Overexpressing Cardiac Angiotensin II AT-1 Receptor

  2013influential citation
• Increased Oxidative Stress in the Nucleus Caused by Nox4 Mediates Oxidation of HDAC4 and Cardiac Hypertrophy

  2013cites this paper
• Arrestins in the cardiovascular system.

  2013cites this paper
• Upregulation of M3 muscarinic receptor inhibits cardiac hypertrophy induced by angiotensin II

  2013cites this paper
• GPCR biased ligands as novel heart failure therapeutics.

  2013cites this paper
• βArrestins in Cardiac G Protein-Coupled Receptor Signaling and Function: Partners in Crime or “Good Cop, Bad Cop”?

  2013cites this paper
• Signalling bias in new drug discovery: detection, quantification and therapeutic impact

  2012cites this paper
• Beta-arrestin biased agonism/antagonism at cardiovascular seven transmembrane-spanning receptors.

  2012cites this paper
• Functionally Selective AT1 Receptor Activation Reduces Ischemia Reperfusion Injury

  2012cites this paper
• The potential for selective pharmacological therapies through biased receptor signaling

  2012cites this paper
• Constitutively active MEK1 rescues cardiac dysfunction caused by overexpressed GSK-3α during aging and hemodynamic pressure overload.

  2012cites this paper
• TRV120027, a Novel &bgr;-Arrestin Biased Ligand at the Angiotensin II Type I Receptor, Unloads the Heart and Maintains Renal Function When Added to Furosemide in Experimental Heart Failure

  2012cites this paper
• Choline inhibits angiotensin II-induced cardiac hypertrophy by intracellular calcium signal and p38 MAPK pathway

  2012cites this paper
• Deciphering biased-agonism complexity reveals a new active AT1 receptor entity.

  2012cites this paper
• Functions of transmembrane domain 3 of human melanocortin-4 receptor.

  2012cites this paper
• Molecular mechanisms regulating chemokine receptor CXCR4 signaling and trafficking

  2012cites this paper
• Biased ligands for better cardiovascular drugs: dissecting G-protein-coupled receptor pharmacology.

  2011cites this paper
• Endogenous Muscle Atrophy F-Box Mediates Pressure Overload–Induced Cardiac Hypertrophy Through Regulation of Nuclear Factor-&kgr;B

  2011cites this paper
• Cardiorenal Actions of TRV 120027 , a Novel ß-Arrestin – Biased Ligand at the Angiotensin II Type I Receptor , in Healthy and Heart Failure Canines A Novel Therapeutic Strategy for Acute Heart Failure

  2011cites this paper
• GRK2 and β-arrestins in cardiovascular disease: Something old, something new.

  2011cites this paper
• Β-arrestin: a signaling molecule and potential therapeutic target for heart failure.

  2011cites this paper
• Differential Roles of GSK-3&bgr; During Myocardial Ischemia and Ischemia/Reperfusion

  2011cites this paper
• G Protein–Dependent and G Protein–Independent Signaling Pathways and Their Impact on Cardiac Function

  2011cites this paper
• Cardiorenal Actions of TRV120027, a Novel ß-Arrestin–Biased Ligand at the Angiotensin II Type I Receptor, in Healthy and Heart Failure Canines: A Novel Therapeutic Strategy for Acute Heart Failure

  2011cites this paper
• Eccentric and concentric cardiac hypertrophy induced by exercise training: microRNAs and molecular determinants.

  2011cites this paper
• LOX-1: A Critical Player in the Genesis and Progression of Myocardial Ischemia

  2011cites this paper
• Therapeutic potential of β-arrestin- and G protein-biased agonists.

  2011cites this paper
• TRV120027, a Novel Beta-Arrestin Biased Ligand at the Angiotensin II Type I Receptor, Unloads the Heart and Maintains Renal Function When Added to Furosemide in Experimental Heart Failure

  2011cites this paper
• The More Complex Renin-Angiotensin System: New Insights Into An Old System

  2011cites this paper
• Biased Ligands for Better Cardiovascular Drugs: Dissecting GPCR Pharmacology G-Protein-Dependent and –Independent Signaling Pathways and their Impact on Cardiac Function Compartmentalization of b-Adrenergic Signals in Cardiomyocytes G-Protein-Coupled Receptor Kinases (GRK) as Therapeutic Targets in

  2011cites this paper
• Dissecting G-Protein-Coupled Receptor Pharmacology

  2011cites this paper
• Functional Selectivity in Adrenergic and Angiotensin Signaling Systems

  2010cites this paper
• Therapeutic potential of functional selectivity in the treatment of heart failure.

  2010cites this paper
• G protein coupled receptors as allosteric proteins and the role of allosteric modulators

  2010cites this paper
• Beyond Desensitization: Physiological Relevance of Arrestin-Dependent Signaling

  2010cites this paper
• β‐Arrestin 1 and 2 stabilize the angiotensin II type I receptor in distinct high‐affinity conformations

  2010cites this paper
• Quantitative Phosphoproteomics Dissection of Seven-transmembrane Receptor Signaling Using Full and Biased Agonists*

  2010cites this paper